Low dose ketamine increases prepulse inhibition in healthy men.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategyGluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for SchizophreniaMemantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.Exploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: implications for cross-species comparisons.The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibitionGenetic models of sensorimotor gating: relevance to neuropsychiatric disorders.Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population.Prepulse inhibition and genetic mouse models of schizophrenia.The effects of memantine on prepulse inhibition.Neurophysiological biomarkers for drug development in schizophrenia.Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamineGlutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism.NMDA receptor antagonist ketamine impairs feature integration in visual perceptionGender differences and the effects of ketamine in healthy volunteers.From prediction error to psychosis: ketamine as a pharmacological model of delusions.Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine.Schizophrenia endophenotypes as treatment targets.The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia.Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.Contributions of experimental psychiatry to research on the psychosis prodrome.Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant?Startle Modification and P50 Gating in Schizophrenia Patients and Controls: Russian Population.Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia.NMDA receptor and schizophrenia: a brief history.Effect of L-theanine on sensorimotor gating in healthy human subjects.Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice.Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.Effects of GABA-B receptor positive modulator on ketamine-induced psychosis-relevant behaviors and hippocampal electrical activity in freely moving rats.Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans.Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val(158) Met polymorphism in adults with 22q11 deletion syndrome.
P2860
Q24645703-F2D2F6F2-3481-4204-88D8-B10081A0E4BBQ26830533-E48BCDC0-6094-4118-9F13-FB9589671FF5Q28082048-F3652B7A-EAA1-48AD-AC7A-19D457461625Q30355399-EC41FD78-09B3-44EB-95BE-8831C783D904Q30362301-D85109E6-D09C-4815-8F87-80DA1AAE6B79Q30366961-2EAFB033-79D4-42B9-9134-C7E0BF496C27Q30444307-A7F3884B-1A92-4995-98AE-FE5A7E5B67D6Q30450055-7601DFD7-E14F-4355-BD2A-783A4327CD17Q30457807-F91D34A3-68E3-4601-9BB8-C8A81F223A42Q30458275-69D330FA-9D30-4CEF-89DE-E28BC61A4048Q30459497-CB4C0D95-B64F-42EC-8B78-86CD7BE5B15DQ30465425-40F2C499-A03C-4018-A925-282E0170BA29Q30478270-D24E5F4E-B97E-4BA5-8E3C-86939CD3DC63Q30485038-37DEA740-F617-411A-844A-C315F583FBA0Q30486447-5AC47B9A-0EA1-45D2-A130-858A7227CB49Q30488646-6346263D-FC08-44A6-99F5-35BD131DC84CQ30489404-2B797003-A580-4FA7-8205-353A0CA81D8EQ30491461-9EB93D99-20CD-4E15-BA37-FFA753733B0CQ34661613-587EE75E-CC99-4A82-A6F9-E82C4D2D7270Q34837403-2C4C2BA1-48ED-46ED-855A-F8EFE8ACB575Q35041262-D0D8B0FD-955D-40AE-86C4-21750EE6DC63Q35883433-091BF48C-F898-461A-8CD9-B09ED09D801BQ36860032-9CEA08FE-C3A0-47ED-BB93-9C0AEAFA6F1AQ36860053-ED9FF1D4-25E0-4EC9-8E4E-9261B8574E99Q36894587-3BF28B34-F83F-456A-B7B4-D27639DDF030Q36936347-60F1D9AA-BC40-4AC9-ABBB-4C8A9829739CQ37338722-4B3AF0A0-EA66-47FE-B81E-5DD2833EE191Q38105535-0B8A7A7C-87AF-4A4B-AC9F-D37EB4123683Q38175023-0D3C2018-3D04-4754-B692-A3825DF95C7EQ38852109-48E032F2-E845-457F-A419-BFE8CC9B4240Q39952791-82F12491-5ADB-4B98-B7A0-94746752A83AQ39998926-E4D488BE-8F46-46B1-B076-50F084A18D2FQ42192369-66AF215A-AF64-44E9-9673-84B1B0E91828Q43821608-0492563B-C002-485D-9A2A-BAF64ACD7991Q46785915-E97ABBC2-452F-4F3B-B4A9-2FD0D27FDD9EQ47746221-C8320DB6-B0C5-4F11-8C1B-4D3F01C85EDCQ47812296-7D5CC450-9EEA-4F75-A56A-09847B93E265Q48126400-75FFB619-AF1A-419F-8280-EB7217A9CFDFQ48135115-9DAA2574-70AA-46A8-B09B-93BC4220683EQ48387730-408714ED-474B-467B-BAD5-9AB8404B6505
P2860
Low dose ketamine increases prepulse inhibition in healthy men.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Low dose ketamine increases prepulse inhibition in healthy men.
@ast
Low dose ketamine increases prepulse inhibition in healthy men.
@en
Low dose ketamine increases prepulse inhibition in healthy men.
@nl
type
label
Low dose ketamine increases prepulse inhibition in healthy men.
@ast
Low dose ketamine increases prepulse inhibition in healthy men.
@en
Low dose ketamine increases prepulse inhibition in healthy men.
@nl
prefLabel
Low dose ketamine increases prepulse inhibition in healthy men.
@ast
Low dose ketamine increases prepulse inhibition in healthy men.
@en
Low dose ketamine increases prepulse inhibition in healthy men.
@nl
P2093
P1433
P1476
Low dose ketamine increases prepulse inhibition in healthy men.
@en
P2093
David R Hemsley
Mark A Geyer
Matthew P G Allin
P304
P356
10.1016/S0028-3908(03)00073-X
P577
2003-05-01T00:00:00Z